fbpx
< All Topics
Print

SARS-CoV-2 Seroprevalence Survey in Grocery Store Workers—Minnesota, 2020–2021

Publication:

MDPI – Multidisciplinary Digital Publishing Institute | March 16th, 2022

https://www.mdpi.com/1660-4601/19/6/3501

Author(s):

Madhure S. Vachon, Ryan T. Demmer, Stephanie Yendell, Kathryn J. Draeger, Timothy J. Beebe, Craig W. Hedberg

Quansys Products Used:

Q-Plex™ SARS-CoV-2 Human IgG (4-Plex)

Abstract:

Grocery workers were essential to the workforce and exempt from lockdown requirements as per Minnesota Executive Order 20–20. The risk of COVID-19 transmission in grocery settings is not well documented. This study aimed to determine which factors influenced seropositivity among grocery workers. We conducted a cross-sectional study of Minnesota grocery workers aged 18 and older using a convenience sample. Participants were recruited using a flyer disseminated electronically via e-mail, social media, and newspaper advertising. Participants were directed to an electronic survey and were asked to self-collect capillary blood for IgG antibody testing. Data were analyzed using logistic regression and adjusted for urbanicity, which confounded the relationship between number of job responsibilities in a store and seropositivity. Of 861 Minnesota grocery workers surveyed, 706 (82%) were tested as part of this study, of which 56 (7.9%) tested positive for IgG antibodies. Participants aged 65–74 years had the highest percent positivity. Having multiple job responsibilities in a store was significantly associated with seropositivity in our adjusted model (OR: 1.14 95% CI: 1.01–1.27). Workplace factors influenced seropositivity among Minnesota grocery workers. Future research will examine other potential factors (e.g., in-store preventive measures and access to PPE) that may contribute to increased seropositivity.

Previous Dietary protein source matters for changes in inflammation measured by urinary C-reactive protein in rural polish women
Next Artemisia gmelinii Attenuates Lung Inflammation by Suppressing the NF-κB/MAPK Pathway